Blood GFAP as an emerging biomarker in brain and spinal cord disorders
Blood GFAP as an emerging biomarker in brain and spinal cord disorders is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Blood GFAP as an emerging biomarker in brain and spinal cord disorders have?
Blood GFAP as an emerging biomarker in brain and spinal cord disorders has 837 citations in the OpenAlex counts ScholarIQ stores.
When was Blood GFAP as an emerging biomarker in brain and spinal cord disorders published?
Blood GFAP as an emerging biomarker in brain and spinal cord disorders has 2022 year in the ScholarIQ index.
What is the open-access status of Blood GFAP as an emerging biomarker in brain and spinal cord disorders?
Blood GFAP as an emerging biomarker in brain and spinal cord disorders has bronze oa status in the ScholarIQ index.
What is the DOI of Blood GFAP as an emerging biomarker in brain and spinal cord disorders?
The DOI for Blood GFAP as an emerging biomarker in brain and spinal cord disorders is on the source record.
What is the PMID of Blood GFAP as an emerging biomarker in brain and spinal cord disorders?
The PMID for Blood GFAP as an emerging biomarker in brain and spinal cord disorders is on the source record.
What is the OpenAlex record for Blood GFAP as an emerging biomarker in brain and spinal cord disorders?
The OpenAlex for Blood GFAP as an emerging biomarker in brain and spinal cord disorders is on the source record.